Suppr超能文献

6-氨基屈在动物和人类肝脏制剂中的生物活化:微粒体和胞质酶系统的作用。

Bioactivation of 6-aminochrysene by animal and human hepatic preparations: contributions of microsomal and cytosolic enzyme systems.

作者信息

Marczylo T, Ioannides C

机构信息

Division of Toxicology, School of Biological Sciences, University of Surrey, Guildford, UK.

出版信息

Mutagenesis. 1994 May;9(3):233-9. doi: 10.1093/mutage/9.3.233.

Abstract

6-Aminochrysene was converted into mutagen(s), in the Ames test in the presence of Aroclor 1254-induced hepatic S9, microsomal and cytosolic fractions, the first being the least and the last the most efficient activation system. The cytosolic activation of 6-aminochrysene decreased in the presence of increasing amounts of microsomes. The Aroclor 1254-induced rat microsomal and cytosolic systems differed markedly in a number of properties, including their cofactor requirements and responses to prototype inducers of the cytochrome P450-dependent mixed-function oxidase system. The cytosolic activation system could also convert 2-aminochrysene to mutagens but not 2- and 6-methylchrysene. Human hepatic cytosol could convert 6-aminochrysene and 2-aminoanthracene to mutagens in the Ames test. It is concluded that a hepatic cytosolic oxygenase exists, totally different from the microsomal oxygenases, which metabolizes aminopolycyclic aromatic hydrocarbons to mutagens, presumably through N-oxidation. This oxygenase activity appears to be present in human hepatic cytosol.

摘要

在艾姆斯试验中,6-氨基屈在存在多氯联苯混合物1254诱导的肝S9、微粒体和胞质部分的情况下被转化为诱变剂,第一种是效率最低的激活系统,最后一种是效率最高的激活系统。随着微粒体数量的增加,6-氨基屈的胞质激活作用降低。多氯联苯混合物1254诱导的大鼠微粒体和胞质系统在许多特性上有显著差异,包括它们的辅因子需求以及对细胞色素P450依赖性混合功能氧化酶系统原型诱导剂的反应。胞质激活系统也可将2-氨基屈转化为诱变剂,但不能将2-甲基屈和6-甲基屈转化为诱变剂。在艾姆斯试验中,人肝细胞溶胶可将6-氨基屈和2-氨基蒽转化为诱变剂。结论是存在一种肝细胞质加氧酶,它与微粒体加氧酶完全不同,该酶可能通过N-氧化作用将氨基多环芳烃代谢为诱变剂。这种加氧酶活性似乎存在于人的肝细胞溶胶中。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验